Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 3:38:100788.
doi: 10.1016/j.bbih.2024.100788. eCollection 2024 Jul.

Central nervous system manifestations following vaccination against COVID-19

Affiliations
Review

Central nervous system manifestations following vaccination against COVID-19

Seyed Sepehr Khatami et al. Brain Behav Immun Health. .

Abstract

Coronavirus disease 2019 (COVID-19) vaccination has become the most effective countermeasure in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. However, vaccination is associated with side effects. This narrative review focuses on central nervous system (CNS) manifestations following COVID-19 vaccination and provides a summary of the potential underlying mechanisms and methods of diagnosis and management of the vaccination-related CNS manifestations. Headache, myalgia, optic neuritis, seizure, multiple sclerosis, acute disseminated encephalomyelitis and encephalitis, delirium, acute transverse myelitis, and stroke have been reported after COVID-19 vaccination. Constant headache and myalgia are common manifestations that may necessitate further clinical investigation for stroke. To limit consequences, it is imperative to follow standard treatment protocols for each neurological disorder following COVID-19 vaccination. Immunosuppressive medication can be helpful in the treatment of seizures following vaccination since the immune response is involved in their etiology. Clinicians should be aware of the manifestations after COVID-19 vaccination to respond promptly and effectively. Clinical guidelines for the management of CNS manifestations following COVID-19 vaccination are in high demand and would be useful in each new SARS-CoV-2 variant pandemic.

Keywords: COVID-19; Central nervous system; Complications; Neurology; SARS-CoV-2; Vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Overview of reported CNS manifestations after COVID-19 vaccination. Note: CNS: Central Nervous System; COVID-19: Coronavirus Disease 2019; ADEM: Acute Disseminated Encephalomyelitis.

Similar articles

Cited by

References

    1. Abboud H., Probasco J.C., Irani S., Ances B., Benavides D.R., Bradshaw M., Christo P.P., Dale R.C., Fernandez-Fournier M., Flanagan E.P., Gadoth A., George P., Grebenciucova E., Jammoul A., Lee S.T., Li Y., Matiello M., Morse A.M., Rae-Grant A., Rojas G., Rossman I., Schmitt S., Venkatesan A., Vernino S., Pittock S.J., Titulaer M.J. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J. Neurol. Neurosurg. Psychiatry. 2021;92(7):757–768. doi: 10.1136/jnnp-2020-325300. - DOI - PMC - PubMed
    1. Abdollahi M., Alidaei N., Ayar A. Spontaneous subarachnoid haemorrhage after COVID-19 vaccination; a rare case report. Arch Clin Infect Dis. 2022;17(5) doi: 10.5812/archcid-127354. - DOI
    1. Achiron A., Dolev M., Menascu S., Zohar D.-N., Dreyer-Alster S., Miron S., Shirbint E., Magalashvili D., Flechter S., Givon U., Guber D., Stern Y., Polliack M., Falb R., Gurevich M. COVID-19 vaccination in patients with multiple sclerosis: what we have learnt by February 2021. Multiple Sclerosis Journal. 2021;27(6):864–870. doi: 10.1177/13524585211003476. - DOI - PMC - PubMed
    1. Agmon-Levin N., Kivity S., Szyper-Kravitz M., Shoenfeld Y. Transverse myelitis and vaccines: a multi-analysis. Lupus. 2009;18(13):1198–1204. doi: 10.1177/0961203309345730. - DOI - PubMed
    1. Alabkal J., Rebchuk A.D., Lyndon D., Randhawa N. Incomplete subacute transverse myelitis following vaccination with Pfizer-BioNtech COVID-19 mRNA vaccine: a case report. Cureus. 2021;13(12) doi: 10.7759/cureus.20460. - DOI - PMC - PubMed

LinkOut - more resources